Particle Shedding in Clean Rooms: Laundered vs. Single Use – The Surprising Verdict

 

Particle Shedding in Clean Rooms: In an increasingly cleanliness-obsessed world, it’s becoming evident that choices regarding the materials we use have far-reaching impacts. This is particularly true in highly controlled environments like clean rooms, where the importance of minimizing particle shedding is paramount. The question arises as to whether reusable or single-use garments should be employed. Comfortability might initially draw us toward the former, but as David Kreitzere, a controlled environments specialist at Dupont, points out, the allure of comfort might be misleading.

Laundered garments, while comfortable, suffer from large pore sizes. This results in significant particle shedding into the clean room, posing a risk to the sterile environment. In contrast, single-use garments such as Tyvek offer nearly complete particle barriers, maintaining a cleaner environment.

Looking past the initial upfront cost comparison, Kreitzer points out the long-term price equivalence. Interestingly, while laundered garments might seem more economical initially, over time the risk of particle shedding in clean rooms increases with each wash cycle. Furthermore, the logistics of laundry services often involve additional costs like surcharges, lost garment fees, and inflexible contracts.

Conversely, with single-use suits like Tyvek, the costs are known upfront. There are no contractual commitments, no surcharges, and, most importantly, no room for the increased risk of contamination through particle shedding.

With this perspective, the choice seems clearer, balancing the pros and cons between initial cost, cleanliness, and long-term efficiency. Let’s hear more from David Kreitzer, who will guide us further on this topic of controlled environments on the show today.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…